BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease.
Saideh FakharzadehHassan ArganiSimin DadashzadehSomayeh KalanakyPeyman Mohammadi TorbatiMohammad Hassan NazaranAbbas BasiriPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
In conclusion, BCc1 as an iron-chelating agent shows promising impacts in DKD animal model, which can ameliorate biochemical and pathological events of this disease.